50% Oxygen/50% Nitrous oxide premix (Kalinox 170 bar)

DRUG2 trials

Sponsors

Air Liquide Santé International

Conditions

BurnsCancerPain

Phase 3

Study of the Efficacy and Safety of Kalinox® 170 Bar for the Performance of Care Procedures in Children With Burns

WithdrawnNCT00643357

Air Liquide Santé InternationalBurns

Start: 2008-03-31End: 2009-01-31Updated: 2012-01-19

Phase 4

Study of the Efficacy of Kalinox® 170 Bar in Adult Oncology

CompletedNCT00646945

Air Liquide Santé InternationalCancer, Pain

Start: 2007-09-30End: 2008-10-31Updated: 2025-09-16